Ex Parte BURCH et al - Page 3




            Appeal No. 2003-0645                                                         3             
            Application No. 09/245,625                                                                 


            the properties of the elastic fiber as set forth in claim 4 on                             
            appeal (i.e., a Group III claim; see Burch, col. 3, l. 59-col. 4,                          
            l. 6).  Appellants have not identified any specific, substantive                           
            reasons for the separate patentability of this claim or any Group                          
            III claim other than the reasons given for the Group I claims                              
            (Brief, pages 12-13).                                                                      
                  Accordingly, we select independent claim 1 as representative                         
            of the claims on appeal and decide the ground of rejection in this                         
            appeal on the basis of this claim alone.  See In re McDaniel, 293                          
            F.3d 1379, 1383, 63 USPQ2d 1462, 1465 (Fed. Cir. 2002)(“If the                             
            brief fails to meet either requirement [of 37 CFR § 1.192(c)(7)],                          
            the Board is free to select a single claim from each group of                              
            claims subject to a common ground of rejection and to decide the                           
            appeal of that rejection based solely on the selected                                      
            representative claim.”).  Claim 1 is reproduced below:                                     
                  1.    A fiber comprising:                                                            
                  (a) a fiber of an elastomeric polymer capable of imbibing a                          
                        chemotherapeutic agent; and                                                    
                  (b) a therapeutically effective amount of the                                        
            chemotherapeutic agent imbibed in the fiber.                                               












Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007